This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
All 13 patients (100%) showed a clinically significant reduction in parenteral support volume.
Why it matters
This research highlights the potential of teduglutide to improve the quality of life for patients with short bowel syndrome, reducing reliance on parenteral nutrition.
How the study worked
A retrospective analysis of 13 patients treated with teduglutide in a specialized program over four years.
What this study cannot tell us
The study is limited by its small sample size and retrospective design, which may affect the generalizability of the findings.
Read the original research
Teduglutide in short bowel syndrome patients: A way back to normal life?
JPEN. Journal of parenteral and enteral nutrition, 46(2), 300-309
Citation
Harpain, Felix; Schlager, Lukas; Hütterer, Elisabeth; Dawoud, Christopher; Kirchnawy, Sabine; Stift, Judith; Krotka, Pavla; Stift, Anton. (2022). Teduglutide in short bowel syndrome patients: A way back to normal life?. JPEN. Journal of parenteral and enteral nutrition, 46(2), 300-309. https://doi.org/10.1002/jpen.2272